Literature DB >> 220562

Cholinergic dysautonomia and Eaton-Lambert syndrome.

A E Rubenstein, S H Horowitz, A N Bender.   

Abstract

Cholinergic autonomic function was abnormal in a 47-year-old woman with Eaton-Lambert syndrome (ELS), not associated with carcinoma. Pupillary constriction to light and accommodation, sweating, lacrimation, and salivation were all affected. There was no evidence of Sjogren syndrome or botulinum intoxication. The defect of acetylcholine release from presynaptic terminals in the Eaton-Lambert syndrome may not be restricted to the neuromuscular junction of skeletal muscle.

Entities:  

Mesh:

Year:  1979        PMID: 220562     DOI: 10.1212/wnl.29.5.720

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome.

Authors:  J P Heath; D J Ewing; R E Cull
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

Review 2.  Postganglionic cholinergic dysautonomia with incomplete recovery: a clinical, neurophysiological and immunological case study.

Authors:  R Baron; F Engler
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

3.  Circulating T cell subsets in the Lambert-Eaton myasthenic syndrome.

Authors:  S A Robb; T J Bowley; H N Willcox; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

4.  Lambert Eaton syndrome: autonomic neuropathy and inappropriate antidiuretic hormone secretion in a patient with small cell carcinoma of the lung.

Authors:  H Manji; M S Schwartz; R O McKeran
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

5.  Autonomic dysfunction in Lambert-Eaton myasthenic syndrome.

Authors:  S A Waterman
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

6.  Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment.

Authors:  D A Ingram; G R Davis; M S Schwartz; M Traub; A C Newland; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

7.  Lambert-eaton myasthenic syndrome.

Authors:  Maria B Weimer; Joaquin Wong
Journal:  Curr Treat Options Neurol       Date:  2009-03       Impact factor: 3.598

Review 8.  Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.

Authors:  Michael T Flink; William D Atchison
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 9.  Paraneoplastic syndromes of the nervous system.

Authors:  G Palma
Journal:  West J Med       Date:  1985-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.